Referentielijst

Alderman J (2005)
Alderman J. Diarrhea in palliative care. Journal of Palliative Medicine 2005; 8: 449-450.
 
American Gastroenterological Association (1999)
American Gastroenterological Association medical position statement: guidelines for the evaluation and management of chronic diarrhea. Gastroenterology 1999; 116: 1461-1463.
 
Attar A (1999)
Attar A, Flourié B, Ramboud JC et al. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover randomized trial. Gastroenterology 1999; 117: 794-797.
 
Benson III AB (2004)
Benson III AB, Ajani JA, Catalano RB et al. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. Journal of Clinical Oncology 2004; 22: 2918-2926.
 
Brühl PhJ (2007)
Brühl PhJ, Lamers HJ, Dongen van AM et al. NHG-standaard acute diarree. Huisarts en Wetenschap 2007; 3 103-113.
 
Cascinu S (1993)
Cascinu S, Fedeli A, Fedeli SL et al. Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial. Journal of Clinical Oncology 1993; 11: 148-151.
 
Cello JP (1991)
Cello JP, Grendell JH, Basuk P et al. Effect of octreotide on refractory AIDS-associated diarrhea. A prospective, multicenter clinical trial. Annals of Internal Medicine 1991; 115: 705-710.
 
Cherny NI (2008)
Cherny NI. Evaluation and management of treatment-related diarrhea in patients with advanced cancer: a review. Journal of Pain and Symptom Management 2008; 36: 413-423.
 
Dean AP (1991)
Dean AP, Reed WD. Diarrhoea - an unrecognised hazard of coeliac plexus block. Australian and New Zealand Journal of Medicine 1991; 21: 47-48.
 
Denton A (2002)
Denton AS, Andreyev HJ, Forbes A et al. Systematic review for non-surgical interventions for the management of late radiation proctitis. British Journal of Cancer 2002; 87: 134-143.
 
Engelking C (1998)
Engelking C, Rutledge DN, Ippoliti C, Neumann J, Hogan CM. Cancer related diarrhea: a neglected cause of cancer-related symptom distress. Oncology Nursing Forum 1998; 25: 859-860.
 
Fried M (1999)
Fried M. Octreotide in the treatment of refractory diarrhea. Digestion 1999; 60 (Supplement 2): 42-46.
 
Gebbia V (1993)
Gebbia V, Carreca I, Testa A et al. Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy. Anticancer Drugs 1993, 4: 443-445.
 
Goumas P (1998)
Goumas P, Naxakis S, Christopoulou A et al. Octreotide acetate in the treatment of fluorouracil-induced diarrhea. Oncologist 1998; 3: 50-53.
 
Harris AG (1995)
Harris AG, Redfern JS. Octreotide treatment of carcinoid syndrome: analysis of published dose-titration data. Alimentary Pharmacology & Therapeutics 1995; 9: 387-394.
 
Harris AG (1995)
Harris AG, O’Dorisio TM, Woltering EA et al. Consensus statement: octreotide dose titration in secretory diarrhea. Diarrhea Management Consensus Development Panel. Digestive Diseases and Sciences 1995; 40: 1464-1473.
 
Hogan CM (1998)
Hogan CM. The nurse’s role in diarrhea management. Oncology Nursing Forum 1998; 25: 879-886.
 
1Ippoliti C (1997)
Ippoliti C, Champlin R, Bugazia N et al. Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematological malignancies. Journal of Clinical Oncology 1997; 15: 3350-3354.
 
Jensen RT (1999)
Jensen RT. Overview of chronic diarrhea caused by functional neuroendocrine neoplasms. Seminars in Gastrointestinal Diseases 1999; 10: 156-72.
 
Kaplan MA (1999)
Kaplan MA, Prior MJ, Ash RR et al. Loperamide-simethicone vs loperamide alone, simethicone alone, and placebo in the treatment of acute diarrhea with gas-related abdominal discomfort. A randomized controlled trial. Archives of Family Medicine 1999; 8: 243-248.
 
Kinnunen O (1989)
Kinnunen O, Jaunhonen P, Salokannel J et al. Diarrhea and fecal impaction in elderly long-stay patients. Zeitschrift für Gerontologie 1989; 22: 321-323.
 
Kornblau S (2000)
Kornblau S, Benson AB, Catalano R et al. Management of cancer treatment-related diarrhea. Issues and therapeutic strategies. Journal of Pain and Symptom Management 2000; 19: 118-129.
 
Mercadente S (1995)
Mercadente S. Diarrhea in terminally ill patients: pathophysiology and treatment. Journal of Pain and Symptom Management 1995; 10: 298- 309.
 
Moertel CG (1991)
Moertel CG, Kvols LK, Rubin J. A study of cyproheptadine in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome. Cancer 1991; 67: 33-36.
 
Mystakidou K (2006)
Mystakidou K, Katsouda E, Tsilika E et al. Octreotide long-acting formulation (LAR) in chronic loperamide-refractory diarrhea not related to cancer treatment. Anticancer Research 2006; 26: 2325-2328.
 
Nwachukwu CE (2008)
Nwachukwu CE, Okebe JU. Antimotility agents for chronic diarrhoea in people with HIV/AIDS. Cochrane Database of Systematic Reviews 2008; 4: CD005644.
 
Noble S (2002)
Noble S, Rawlinson F, Byrne A. Acquired lactose intolerance: a seldom considered cause of diarrhea in the palliative care setting. Journal of Pain and Symptom Management 2002; 23: 449-450.
 
Palmer KR (1980)
Palmer KR, Corbett CL, Holdsworth CD. Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea. Gastroenterology 1980; 79: 1272-1275.
 
Romeu J (1991)
Romeu J, Miró JM, Sirera G et al. Efficacy of octreotide in the management of chronic diarrhoea in AIDS. AIDS 1991; 5: 1495-1499.
 
3Rubin J (1999)
Rubin J, Ajani J, Schirmer W et al. Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome. Journal of Clinical Oncology 1999; 17: 600-606.
 
Ruppin H (1987)
Ruppin H. Review: loperamide – a potent antidiarrhoeal drug with actions along the alimentary tract. Alimentary Pharmacology & Therapeutics 1987; 1: 179-190.
 
Rutledge DN (1998)
Rutledge DN, Engelking C. Cancer-related diarrhea: selected findings of a national survey of oncology nurse experiences. Oncology Nursing Forum 1998; 25: 861-873.
 
Szilagyi A (2001)
Szilagyi A, Shrier I. Systematic review: the use of somatostatin or octreotide in refractory diarrhea. Alimentary Pharmacology & Therapeutics 2001; 15: 1889-1897.
 
Thomas PD (2003)
Thomas PD, Forbes A, Green J et al. Guidelines for the investigation of chronic diarrhoea, 2nd edition. Gut 2003; 52: (Supplement 5): v1-v15.
 
Tilg H (2008)
Tilg H. Short bowel syndrome : searching for the proper diet. European Journal of Gastroeenterology and Hepatology 2008; 20: 1061-1063.
 
Yavuz MN (2002)
Yavuz MN, Yavuz AA, Aydin F et al. The efficacy of octreotide in the therapy of acute radiation-induced diarrhea : a randomized controlled study. International Journal of Radiation Oncology, Biology, Physics 2002; 54: 195-202.
 
Zidan J (2001)
Zidan J, Haim N, Beny A et al. Octreotide in the treatment of severe chemotherapy-induced diarrhea. Annals of Oncology 2001; 12: 227-229.